Although research on CBDA is still in its early stages, there is evidence to suggest that it may interact with the endocannabinoid system (ECS), just like CBD and other cannabinoids. CBDA has been shown to inhibit the production of cyclooxygenase-2 (COX-2) enzymes. While CBDA doesn't directly bind to CB1 or CB2 receptors in the same way that THC does, it may indirectly influence the endocannabinoid system. Research suggests that CBDA may interact with other receptors and enzymes in the ECS, potentially modulating the effects of other cannabinoids.
As a cannabinoid, CBDA attaches itself to cannabinoid receptors belonging to the endocannabinoid system, a bodily system found in every mammal. This attachment process allows the body’s cannabinoid receptors to regulate the functions of nearby bodily processes, playing a role in creating a state of homeostasis within the body.